XML 36 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation Expense Included in Operating Expense

Stock-based compensation expense was included in the following operating expense categories:

 

 

Year Ended December 31,

 

(In Thousands)

 

2024

 

 

2023

 

Cost of revenue

 

$

24

 

 

$

2

 

Sales and marketing

 

 

308

 

 

 

663

 

Product development

 

 

54

 

 

 

114

 

General and administrative

 

 

1,321

 

 

 

1,614

 

Total stock-based compensation

 

$

1,707

 

 

$

2,393

 

Assumptions to Estimate Fair Value for Stock Options at Grant Date

The following assumptions were used in determining the fair value of time-vested stock options granted for the periods indicated:

 

 

Year Ended December 31,

 

 

2024

 

2023

Expected life (in years)

 

4.00 - 6.25

 

4.00 - 6.25

Risk-free interest rate

 

3.93% - 4.43%

 

3.86% - 3.93%

Expected volatility

 

57% - 64%

 

57% - 64%

Stock Option Activity

Stock option activity during the period is as follows:

 

Options
(in thousands)

 

Weighted
average
exercise price
of options

 

Weighted average
remaining
contractual term
(in years)

Balance at December 31, 2023

5,395

 

$2.21

 

7.39

Options granted

2,012

 

1.61

 

 

Options forfeited

(180)

 

1.63

 

 

Options expired

(188)

 

6.84

 

 

Options exercised

 

 

 

 

Balance at December 31, 2024

7,039

 

$1.91

 

7.57

Summary of Restricted Stock Awards and Restricted Stock Units

Restricted stock awards and restricted stock unit activity during the period is as follows:

 

 

Shares/
Units
(In Thousands)

 

 

Weighted Average
Grant Date
Fair Value

 

Unvested at December 31, 2023

 

 

782

 

 

$

1.94

 

Granted

 

 

 

 

 

 

Vested

 

 

(361

)

 

 

1.96

 

Forfeited

 

 

(15

)

 

 

1.46

 

Unvested at December 31, 2024

 

 

406

 

 

$

2.04